Press Releases

Date Title and Summary Additional Formats
Toggle Summary Life Science Leaders Gather at Medidata NEXT Basel and Frankfurt to Examine New Opportunities to Improve Clinical Development and Better Patient Lives
Where Life Sciences Leaders Meet Transformative Technology Meets the Future LONDON --(BUSINESS WIRE)--Mar. 28, 2018-- Medidata (NASDAQ:MDSO) successfully hosted NEXT conferences in Basel and Frankfurt , with executives from global life sciences and pharmaceutical companies presenting, including
Toggle Summary How Do Technology and Data Accelerate Precision Medicine in Oncology? Industry Experts to Discuss During Medidata Webinar
NEW YORK --(BUSINESS WIRE)--Mar. 15, 2018-- Oncology is leading the precision medicine revolution, as clinical researchers leverage and identify biomarkers to target patient subsets with more effective treatments, and the promise of improving Phase I success rate probability by three times (25.9%
Toggle Summary Medidata to Present at Morgan Stanley Technology, Media & Telecom Conference
NEW YORK --(BUSINESS WIRE)--Feb. 21, 2018-- Medidata (NASDAQ:MDSO) today announced that Tarek Sherif , chief executive officer, and Rouven Bergmann , chief financial officer, will present at the Morgan Stanley Technology, Media & Telecom Conference on Wednesday, February 28, 2018 , at 11:15 a.m.
Toggle Summary Santen Pharmaceutical to Leverage Medidata Edge CTMS to Drive Future Growth in Ophthalmic Clinical Development
Company adopts Edge CTMS in Japan as part of rapid global expansion NEW YORK --(BUSINESS WIRE)--Feb. 20, 2018-- Santen Pharmaceutical Co., Ltd , is expanding its use of the Medidata Clinical Cloud® with the adoption of Edge CTMS (Clinical Trial Management System) to support its clinical trial
Toggle Summary Medidata and eClinical Solutions LLC Mark 10-Year Anniversary Milestone With Expansion Agreement to Adopt Medical Imaging and Workflow Solutions
Industry-leading Data Management Provider Adopts Rave Imaging to Optimize Workflow, Simplify Image and Data Collection, and Improve Efficiency in Clinical Development NEW YORK --(BUSINESS WIRE)--Feb. 15, 2018-- Medidata (NASDAQ: MDSO) today announced that eClinical Solutions LLC , an
Toggle Summary Medidata Named One of 100 Most Sustainable Companies in the U.S. by Barron's Magazine
NEW YORK --(BUSINESS WIRE)--Feb. 14, 2018-- Medidata (NASDAQ:MDSO) has been named to Barron’s first annual list of the “ 100 Most Sustainable Companies ” in the U.S., demonstrating the company's positive impact in five categories: shareholders, employees, customers, community and planet.
Toggle Summary Aperio Adds Medidata Edge eTMF and CTMS in Expansion Agreement
Leading clinical research organization moves to the industry’s only unified platform to maximize efficiencies and outcomes NEW YORK --(BUSINESS WIRE)--Feb. 13, 2018-- Aperio, a leading clinical research organization (CRO) formerly known as iNNO Clinical Outcomes, has expanded its use of the
Toggle Summary Medidata Introduces New Edge Family of Products for Clinical Operations at SCOPE 2018
Life Science Buyers Identify Top Criteria to Support the New Generation of Trials Edge Strategic Monitoring is Only RBM Solution to Address 95% of TransCelerate Technical Requirements and be Fully Compliant with ICH GCP E6 (R2) Requirements NEW YORK --(BUSINESS WIRE)--Feb.
Toggle Summary Medidata Solutions to Host Annual European NEXT Conference Series
Events in Basel , Frankfurt and London Bring Together Industry Leaders to Reinvent Technology’s role in Transforming Clinical Development NEW YORK --(BUSINESS WIRE)--Feb. 12, 2018-- Medidata Solutions (NASDAQ:MDSO), is pleased to announce the 13 th annual NEXT Conference series will commence in
Toggle Summary Medidata Ushers in Era of Choice as Life Science Companies Can Now Conduct Both Virtual and On-site Clinical Trials on One eClinical Platform
Majority of virtual trials are now run on Medidata Clinical Cloud®, the industry’s only unified eClinical platform to fully support all manner of pragmatic study designs NEW YORK --(BUSINESS WIRE)--Feb. 8, 2018-- Medidata (NASDAQ:MDSO) announced today that its virtual trials platform, Engage, is

Investor Contact

Betsy Frank
+1 917 522 4620